CompletedNCT05557643
Psilocybin therapy and mindfulness for frontline healthcare burnout
About this title
Read the official source — NCT05557643Medication studyAges 25+United StatesDepression
Understand this study
Who was this study for?
Listed age limits: from 25 years.
- Listed locations
- Salt Lake CitySee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: January 2, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- University of Utah
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 25 Years
- Official registry ID
- NCT05557643
- Official title
Show the full official title
PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Utah, a university.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin.
Who was this study for?
Listed age limits: from 25 years.
